| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,576 |
1,351 |
$66K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,791 |
1,737 |
$37K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,880 |
1,808 |
$36K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,011 |
1,939 |
$34K |
| 87481 |
|
1,011 |
574 |
$25K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
774 |
743 |
$24K |
| 88141 |
|
1,154 |
1,106 |
$23K |
| 87625 |
|
1,039 |
953 |
$22K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,192 |
1,105 |
$21K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
992 |
954 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
388 |
255 |
$8K |
| 88312 |
|
53 |
50 |
$3K |
| 88112 |
|
30 |
27 |
$535.72 |
| 0753T |
|
51 |
35 |
$0.32 |